| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |